throbber
0001
`
`PSG2026
`Catalent Pharma Solutions v. Patheon Softgels
`IPR2018-00422
`
`

`

`MERCK & (30., INC.
`Whitehouse Station, N.J .
`U. S .A.
`
`lst Edition—1889
`2nd Edition—1896
`3rd Edition—1907
`4th Edition—1930
`5th Edition—1940
`6th Edition—1952
`7th Edition—1960
`8th Edition—1968
`9th Edition—1976
`10th Edition—1983
`11th Edition—4 989
`
`Library of Congress Catalog
`Card Number 89—60001
`ISBN Number 0911910—12—3
`
`First Printing—March 1996
`
`Second Printing—April 1997
`
`Copyright © 1996 by MERCK & CO., INC.
`All rights reserved. Copyright under the Universal Copyright Convention
`and the International Copyright Convention.
`Copyright reserved under the Pan-American Copyright Convention.
`Printed in the U.S.A.
`
`0002
`
`0002
`
`

`

`Abbreviations and Selected Definitions
`Please consult the Glossary (Misc. Tables Section)for additional definitions.
`adenine; adenosine; absorbance ~
`A.S.T.M.
`(extinction)
`Angstrom units
`al—antitrypsin
`antibody -
`absolute; absorption
`absolute configuration
`abstract
`or—aminobutyric acid
`acetyl CH3CO—
`according
`angiotensin converting enzyme
`acetyl coenzyme A
`acetic anhydride
`ethyl acetate
`acetic acid
`acyl carrier protein
`American Chemical Society
`adrenocorticotropic hormone
`acyl coenzyme A
`antibody—dependent cellular
`cytotoxicity
`adding, addition
`adenine
`
`alcohol dehydrogenase
`adenosine diphosphate
`(United States) Atomic Energy
`Commission
`antigen, silver
`anaphylotoxin inhibitor
`acquired immunodeficiency
`syndrome
`alanine
`alcohol(ic); ethanol; ethyl alcohol
`antialymphocyte globulin
`alkali(ne)
`specific optical rotation at 25° C for
`D (sodium) line; absence of
`brackets indicates optical rotation
`of a liquid in a l decimeter cell,
`neat
`
`anti—lymphocyte serum, amyotrophic
`lateral sclerosis
`molar absorptivity (concn in
`g—moles/l)
`amorphous
`adenosine 5 ’—monophosphate
`(adenylic acid)
`cyclic AMP
`ampules
`amount(s)
`anti—nuclear factor; atrial natriuretic
`factor
`anhydrous
`stereodescriptor, see Glossary
`Justus Liebig’s Annalen der Chemie
`American Pharmaceutical
`Association
`approximate(ly)
`alum precipitated toxoid
`aqueous
`aryl
`analytical reagent
`AIDS related complex
`Naunyn Schmiedebergs Archivfifiir
`Experimentelle Pathologie und
`Pharmakologie
`aromatic acyl radical
`arginine
`B-carboxyaspartic acid
`asparagine
`aspartic acid
`association; associated
`
`xiii
`
`0003
`
`RP.
`B. P. C.
`Brit. pat.
`BRM
`BSA
`Btu
`Bu
`Bz
`BzH
`132018
`
`c C °
`
`C
`
`CPca.
`CA.
`cal
`calc(d)
`Can. pat
`Cbz
`cbc
`CC
`CCK
`CD
`CDP
`CEA
`cf-
`CPA
`
`CFT
`CHD
`CHF
`chem
`Chem. Commun.
`
`Ci
`Cl.
`cis-
`cm
`
`aS—, asym—
`at.
`ATCC
`atm, atmos
`at. no.
`ATP
`ATPase
`at. Wt.
`BAN
`B cell
`
`BCG
`Be
`Beilstez'n
`
`Belg. pat.
`Ber.
`
`BGG
`biol
`B.I.O.S.
`
`BOC
`B.O.D.
`boil.
`bp
`
`
`
`American Society for Testing
`Materials
`asymmetrical, unsymmetrical
`atomic
`
`American Type Culture Collection
`atmosphere(s), atmospheric
`atomic number
`adenosine triphosphate
`adenosine triphosphatase
`atomic weight
`British Approved Name
`bone marrow or bursa of Fabricius
`derived cell
`Bacillus Calmette-Guerin
`Baumé (a specific gravity scale)
`Beilstein ’s Handbuch der
`Organischen Chemie
`Belgian patent
`Chemische Berichre (Berichte der
`Deutschen Chemischen
`Gesellschaft)
`bovine gamma globulin
`biological
`British Intelligence Objectives
`Subcommittee
`tent—butoxycarbonyl
`biochemical oxygen demand
`boiling
`basepair; boiling point; boils at;
`boiling at Example: bp70 48°
`means boils at 48°C if the pressure
`is 70 mm Hg
`British Pharmacopez'a
`British Pharmaceutical Codex
`British patent
`biological response modifier
`bovine serum albumin
`British thermal units
`butyl
`benzoyl CGHSCO—
`benzaldehyde
`benzoic acid
`concentration by volume (g/l 00ml)
`after optical rotations only
`cytosine; cytidine; complement
`Centigrade degrees; Celsius
`degrees
`heat capacity (constant pressure)
`(circa) about
`Chemical Abstracts
`calorie(s)
`calculate, calculated
`Canadian patent
`carbobenzoxy
`complete blood count
`cubic centimeter(s) (milliliter)
`cholecystokinin
`circular dichroism
`cytidine diphosphate
`carcinoembryonic antigen
`(confer) compare
`complete Freund’s adjuvant (same as
`FCA)
`complement fixation test
`coronary heart disease
`congestive heart failure
`chemical
`Journal of the Chemical Society,
`Chemical Commu ications.
`curie
`
`Colour Index (British)
`stereodescriptor, see Glossary
`centimeter(s)
`
`A A A
`
`AT
`Ab
`abs
`
`abs config
`abstr
`Abu
`Ac
`acc
`ACE
`Acetyl CoA
`AczO
`AcOEt
`AcOH
`ACP
`A.C.S.
`ACTH
`AcylSCoA
`ADCC
`
`add(n)
`Ade
`ADI-l
`ADP
`ABC
`
`Ag
`AI
`AIDS
`
`Ala
`alc, alcoh
`ALG
`alk
`[0:]?
`
`ALS
`
`0M
`
`amorph
`AMP
`
`cAMP
`amps
`amt(s)
`
`anhydr
`anti
`Ann.
`APhA
`
`approx
`APT
`aq
`Ar
`A.R.
`ARC
`Archiv Exp.
`Pathol. _
`Pharmakol.
`
`Asp
`assoc(d)
`
`0003
`
`

`

`CM—cellulose
`CMl
`CML
`CMP
`
`CNS
`CoA or CoASH
`coll. vol.
`compd
`compn
`Con A
`conc(d)
`concn
`
`config
`constit
`contd
`contg
`CoQ
`cor(r)
`corresp
`CP
`(1P,
`cpd
`crit press
`crit temp
`cryst
`crystn
`CSF
`
`CTFA
`
`CTP
`Cy
`Cyt
`
`Da
`DEAE cellulose
`dec, decomp
`decompn
`deg
`deliquesc
`A (delta)
`
`deriv
`determn
`DFP, DEF, DEEP
`
`Dha
`Dhb
`
`diff
`dil(d>7 (n)
`distln
`dl—
`DL-
`
`dm
`DMA
`DMARD
`DM‘E
`DMSO
`DNA
`cDNA
`mtDNA
`DNAase
`DNEB
`DNP
`
`, P
`up, DP
`
`0-(carboxymethyl) cellulose
`cell—mediated immunity
`cell—mediated lymphocytotoxicity
`cytidine 5’—monophosphate (cytidylic
`acid)
`central nervous system
`coenzyme A
`collective volume
`compound
`composition
`concanavalin A
`concentrated
`concentration
`configuration
`constituent
`continued
`containing
`coenzyme Q (ubiquinone)
`corrected
`corresponding, corresponds
`centipoise
`chemically pure
`compound
`critical pressure
`critical temperature
`crystalline, crystals
`crystallization
`colony stimulating factor; cerebral
`spinal fluid
`Cosmetic, Toiletry and Fragrance
`Assoc.
`cytidine triphosphate
`cysteine
`cytosine
`density; specific gravity (dl9 specific
`gravity at 19° referred to water at
`4°)
`dextr0(rotatory), the opposite of l
`dextro (in confi'gurational sense
`only), the opposite of L
`daltons
`
`O-(diethylaminoethyl)cellulose
`decompose(s), decomposition
`decomposition
`degree
`deliquescent
`indicates the locant of the double
`bond
`derivative
`determination
`diisopropyl fluorophosphate or
`diisopropyl phosphofluoridate
`dihydroalanine
`dehydrobutyrine,
`B-methyldehydroalanine
`difference
`dilute, diluted, dilution
`distillation
`racemic
`optically inactive by external
`compensation as contrasted with
`meso—
`
`D.R.P.
`
`ds
`DTT
`dyn
`(E)-
`1%
`Elem
`
`EAA
`EAC
`
`EAE
`
`EC
`ECF—A
`
`ECG
`EC. No.
`ed.
`ED
`Ed(s).
`EDTA
`EEG
`e.g.
`EGF
`eidem
`ElNECS
`
`EKG
`ELISA
`emf
`en
`endo-
`
`EPA
`EPO
`
`a (epsilon)
`
`5%
`equilib
`equiv
`esp
`esu
`Et
`a (eta)
`er al.
`etc.
`EtzO
`EtOl—l
`
`Eur. pat. Appl.
`ev
`evac
`
`evapn
`exo-
`
`]
`
`I
`
`expt(ly)
`extra)
`extern
`°F
`F— l —P
`E—o-P
`FA
`=FAB
`
`
`
`decimeter(s)
`dimethylacetamide
`disease modifying antirheumatic drug I
`dimethylformamide
`dimethylsulfoxide
`deoxyribonucleic acid
`complementary DNA
`mitochondrial DNA
`deoxyribonuclease
`2,4-dinitro—l—fiuorobenzene
`2,4—dinitrophenyl or 2,4—
`dinitrophenol
`dihydroxyphenylalanine
`degree of polymerization (number of
`monomeric units in the polymer)
`
`I
`
`XlV
`
`0004
`
`FAD (FADHZ)
`
`rCA
`
`Pd
`EDA.
`
`FD&C
`
`(Deutsches ReichS—Patentheman
`patent
`double stranded
`dithiothreitol
`dynes
`entgegen, stereodescriptor, see
`Glossary
`the absorbance of a solution
`containing one gram per 100 ml
`contained in a cell having an
`absorption path of one cm
`molar extinction coefficient (concn in
`g-moles/l)
`excitatory amino acid
`erythrocyte coated by antibody and
`complement
`experimental allergic
`encephalomyelitis
`electron capture
`eosinophil chemotactic factor of
`anaphylaxis
`electrocardiogram
`Enzyme Commission Number
`edition
`effective dose
`editor(s)
`ethylenediaminetetraacetic acid
`electroencephalogram
`(exempli gratia) for example
`epidermal growth factor
`the same (authors), plural of idem
`European Inventory of Existing
`Chemical Substances
`electrocardiogram
`enzyme—linked immunosorbent assay
`electromotive force
`ethylenediamine (in formulas)
`stereochemical descriptor, see
`Glossary
`Environmental Protection Agency
`erythropoietin; European Patent
`Office
`
`molar extinction coefficient (concn in
`g-moles/l); dielectric constant
`equation
`equilibrium
`equivalent
`especially
`electrostatic units of electrical charge
`ethyl (321—13—
`viscosity
`(et alii) and others
`et cetera
`ether
`ethyl alcohol
`European patent application
`electron volt
`evacuated
`evaporation
`stereochemical descriptor, see
`Glossary
`experimentalfly)
`extract, extracted
`externally
`Fahrenheit degrees: also Fourneau
`fructose l-phosphate
`fructose 6—phosphate
`fatty acid
`fast atom bombardment
`fiavin adenine dinucleotide (reduced
`form)
`Freund’s complete adjuvant (same as
`CPA)
`ferredoxin
`Food and Drug Administration
`(U.S.A.)
`.
`Food, Drug and Cosmetic (USA).
`
`0004
`
`

`

`GVH
`habit.
`Har
`Hb
`HbCO
`
`Hb02
`HCG
`Hey
`HDL
`HeLa
`
`HGG
`HGH
`His
`HIV
`Hiv
`HLA
`l-lMG—CoA
`
`Houben
`
`Houben Weyl
`
`HPLC
`
`hr
`HSA
`Hse
`HSV
`HT
`‘ HTLV
`
`IARC
`
`ZARC Monographs
`
`ibid.
`l.C.C.
`ICFA
`
`lCSH
`
`EDDM
`idem
`
`
`
`FDNB
`FD
`ff
`FFA
`PFC
`FIA
`
`FIAT
`
`FMN (PNINHZ)
`
`Fmoc
`Forrschr. Chem.
`Org. Natursz‘.
`
`fp
`FP
`PPLC
`Fr. pat.
`Frdl.
`
`l—fluoro—2,4—dinitrobenzene
`fructose l,6-diphosphate
`following
`free fatty acid
`free from chlorine
`Freund’s incomplete adjuvant (same
`as ICFA)
`Field Information Agency, Technical
`(U.S. reports)
`fiavin mononucleotide (reduced
`form); same as riboflavin
`phosphate
`9-fluorenylmethoxycarbonyl
`Forfschrine der Chemie Organischer
`Natursrofi‘e (Progress in the
`Chemistry of Organic Natural
`Products)
`freezing point
`flavoprotein
`fast protein liquid chromatography
`French patent
`P. Fn’edlander Fortschrizre der Teer—
`farbenfabrikarion, a collection of
`patents
`fructose
`
`GLC
`Gch
`GlcN
`GlcNAc
`GlcUA
`Gin
`Gin
`GluA
`Gly
`Glycerol—34D
`Gmelz’n ’s
`
`follicle—stimulating hormone
`Fourier transform
`gram(s)
`guanine; guanosine
`glucose l—phosphate
`glyceraldehyde 3—phosphate
`glucose 6—phosphate
`y—aminobutyric acid
`gallon(s)
`galactose
`N-acetyl—D—galactosarmne
`microgram(_s)
`gas chromatography
`glutamate dehydrogenase
`guanosine diphosphate
`geminal, stereodescriptor see
`Glossary
`geological
`German patent
`growth hormone
`gastrointestinal
`grams per liter
`y—carboxyglutamic acid
`glucose
`gas—liquid chromatography
`gluconic acid
`glucosamine
`N—acetyl—D-glucosamine
`glucuronic acid
`glutamine
`glutamic acid
`glucuronic acid
`glycine
`glycerol 3—phosphate
`Gmelin’s Handbuch der
`Anorganischen Chemic, a
`comprehensive German
`encyclopedia of inorganic
`chemisny
`guanosine 5 ’~monophosphate
`(guanylic acid)
`cyclic GMP
`granulocyte macrophage colony
`stimulating factor
`government
`glycoprotein
`growth hormone releasing factor
`glutathione (reduced)
`glutathione (oxidized)
`guanosine triphosphate
`genitourinary
`guanine
`
`0005
`
`incl
`incompat
`.INN
`
`XV
`
`graft—versus—host
`habitat
`homoarginine
`hemoglobin
`carbon monom'de hemoglobin;
`carboxyhemoglobin
`oxyhemoglobin
`human chorionic gonadotropin
`homocysteine
`high density lipoproteins
`cells of the first continuously
`cultured (human cervical)
`carcinoma strain
`human gamma globulin
`human growth hormone
`histidine
`
`human immunodeficiency virus
`a—hydroxyisovahne
`human leukocyte antigen
`3—hydroxy-3—methylglutaryl
`coenzyme A
`a German collection of medicinal
`patents
`Houben—Weyl Methoden der
`Organischen Chemie, a German
`collection of preparative methods
`in organic chemistry
`high performance (pressure, power)
`liquid chromatography
`hour
`human serum albumin
`homoserine
`herpes simplex Virus
`hydroxytryptamine (serotonin)
`human T lymphotropic Virus see also
`HIV
`hydroxylysine
`hydroxyproline
`optically inactive by internal
`compensation as i—inositol; archaic
`for meso—
`inosine
`
`l-region antigen
`International Association of Cancer
`Registries
`international Agency for Research on
`Cancer
`I'ARC Monographs on the Evaluation
`of Carcinogenic Risk of Chemicals
`to Man
`
`(i’oidem) at the same place
`Interstate Commerce Commission
`incomplete Freund’s adjuvant (same
`as PIA)
`interstitial cell—stimulating hormone
`(same as Ll—l)
`insulin dependent diabetes mellitis
`the same (author); plural: eidem, the
`same (authors)
`inosine diphosphate
`(id est) that is
`lsoelecnic focusing
`interferon
`intragastric
`immunoglobulin
`Interessengemeinschafz der
`Forbenz’ndusm'e, Akfiengesellschqfi~
`the German dye trust
`insulin—like growth factor 1
`interleukin
`isoleucine
`intramuscular
`inosine 5’—monophosphate (inosinic
`acid)
`including
`incompatibility
`International Nonproprietary Name
`
`0005
`
`

`

`mcg
`mCi
`
`MD
`
`MDH
`Me
`MeZCO—
`MeOH
`Mellor’s
`
`mEq
`
`Met
`fMet
`MetHb
`meV
`mfg, manur"
`mfr
`mg
`MHC
`mCi
`mg
`microcryst
`MEmm
`MIS
`misc
`mixt
`ml
`NILD
`MLR
`mm
`
`mpu
`mol wt
`Monatsh.
`mOsrn
`mp
`
`Mr
`NIRi
`ms-
`MS
`MSH
`
`7L
`
`N
`
`NAcneu
`NAD+ (NADI-I)
`
`NADP+ (NADPl-l)
`
`NANSAIDS
`
`NBS
`NCTC
`NDP
`Neth. pat. Appl.
`NF.
`Hg
`NGF
`NioDM
`
`MOSH
`
`nm L
`NW '
`
`(ll—NINE)
`
`inorganic
`insoluble
`internal
`International
`intraperitoneal
`infrared
`immune responsegenes
`Internal Organization for
`Standardization
`
`_
`_
`isolation
`inosine triphosphate; idiopathic
`thrombocytopenic purpura
`international unit
`International Union of Chemistry
`International Union of Pure and
`Applied Chemistry
`intravenous
`apanesel patent (unexamined)
`Japanese patent
`dissociation constant; equilibrium
`constant
`degrees Kelvin
`kilobase
`kilocalories(s)
`killer cell
`kilogram(s)
`oc—ketoglutarate
`keyhole limpet hemocyanin
`kidney plasminogen activator
`liter
`levo(rotatory), the opposite of d
`levo (in configurational sense only),
`the opposite of D
`lactose
`lymphocyte-activating determinant
`wavelength
`laser microprobe mass analysis
`long acting thyroid stimulator
`pound(s)
`lethal concentration; liquid
`chromatography
`median lethal concentration, the
`concn of a chemical that is
`estimated to be fatal to 50% of the
`organisms tested
`lymphocyte Choriomeningitis
`lethal dose
`median lethal dose, the quantity of a
`chemical that is estimated to be
`fatal to 50% of the organisms
`tested
`lactate dehydrogenase
`low density lipoproteins
`leucine
`luteinizing hormone (same as ICSH)
`natural logarithm
`(loco citato) in the place cited
`logarithm (common)
`limit of impurities
`lipopolysaccharide
`lysme
`meter; given after mass number
`signifies metastable isomer
`meta chemical locant for ring
`substituents
`molar (concentration)
`monoclonal antibody
`maximum allowable concentration
`
`macrophage activating factor
`monoamine oxidase
`monoamine oxidase inhibitor
`mass spectrometry
`maximum, maxima
`myoglobin
`oxymyoglobin
`Manufacturing Chemists Association
`(USA)
`
`
`
`u
`Ym
`
`0006
`
`microgram
`milhcune
`
`at D X mol wt
`100
`
`,
`molecular rotation
`malate dehydrogenase
`methyl CH3—
`acetone
`
`methyl alcohol
`Mellor’s Comprehensive Treatise on
`Inorganic and Theoretical
`Chemistry
`milli—equivalent (0.001 of an
`equivalent)
`methionine
`N—formylrnethionine
`methemoglobin
`millielectron volts
`manufacturing
`manufacture
`
`milligram
`major histocompatibility complex
`microcurie
`
`micrograrn
`microcrystalline
`migration inhibition factor
`minimum; minute(s)
`Mullerian inhibiting substance
`miscible
`mixture
`milliliter (cubic centimeter)
`minimum lethal dose
`mixed lymphocyte reaction
`millimeter
`millimicron(s), 11m
`molecular weight
`Monatshefte flir Chemie
`milliosmolar
`melting point; melts, melting at,
`when followed by a figure
`denoting temperature
`relative molecular mass
`magnetic resonance imaging
`meso- (internally compensated)
`mass spectrometry
`melanocyte-stimulating hormone
`(melanotropin)
`index of refraction (n? for 20° and
`sodium light); normal as n—propyl
`normal (equivalents per liter, as
`applied to concentration); nitrogen
`(asin N~methylpyridine)
`N-acetylneuraminic acid
`nicotinamide adenine dinucleotide
`(reduced form)
`nicotinarmde adenine dinucleotide
`
`phosphate (reduced form)
`nonaspirin nonsteroidal anti—
`inflammatory drugs
`National Bureau of Standards
`National Collection of Type Cultures
`nucleoside 5’-phosphate
`Netherlands patent application
`National Formulary
`nanogram (10—9 grams)
`nerve growth ractor
`Non-insulin dependent diabetes
`mellitis
`National Institute for Occupational
`Safety and Health
`nanometer
`nicotinamide mononucleotide
`(reduced form)
`nucleoside 5 ’—monophosphate
`nuclear magnetic resonance
`New and Nonofiicial Drugs
`(Lippincott, 1959-1964)
`
`inorg
`insol
`intern
`Intl
`
`i.p.
`IR
`Ir genes
`ISO
`
`isoln
`IT?
`
`LU.
`I.U.C.
`I.U.P.A.C.
`
`i.v.
`Japan. Kokai
`Japan. pat.
`
`K °
`
`K
`
`Lac
`LAD
`)1 (lambda)
`LAMMA
`LATS
`lb
`LC
`
`LCso
`
`LCM
`LD
`LDso
`
`LDH
`LDL
`Leu
`LH
`ln
`loc. cit.
`log
`I oi
`LPS
`Lysm
`
`m-
`
`M M
`
`ab, mAb
`MAC
`MAP
`MAO
`MAOI
`mass spec
`max
`Mb
`Mb02
`M.C.A.
`
`0006
`
`

`

`N.N.R.
`
`110.
`7107‘-
`
`PAGE
`passim
`pat.
`PB report
`
`PCA
`PCT
`PEP
`PET
`petr, etrol
`PFC p
`3PG
`PG
`PGA
`' GP
`pH
`
`FHA
`Phe
`physiol
`
`New and Nonofficial Remedies
`(Lippincott, 1933-1958)
`number
`chemical nomenclature descriptor,
`see Glossary
`National Research Development
`Corporation
`nonsteroidal anti-inflammatory
`drugs
`National Service Center
`nucleoside 5’—uiphosphate; National
`Toxicology Program (US)
`ortho chemical locant for ring
`substituents
`denoting attachment to oxygen, as in
`0- acetylhydroxylamine
`ovalbumin
`oxaloacetate
`optical density
`(opera ciraro) in the work cited
`organic
`Occupational Safety and Health Act
`osmolar
`ounce(s)
`concentration by weight (after optical
`rotations only)
`page(s)
`para chemical locant for ring
`substituents
`inorganic phosphate
`pascal
`p-aminobenzoic acid
`platelet—activating factor
`polyacrylamide gel electrophoresis
`here and there, scattered
`patent
`Publication Board Report (United
`States Department of Commerce,
`Scientific and Industrial Reports)
`passive cutaneous anaphylaXis
`Patent Co-operation Treaty
`phosphoenolpyruvate
`positron emission tomography
`petroleum
`plaque—forming cell
`3-phosphoglycerate
`prostaglandin
`pteroylglutarnic acid (folic acid)
`3—phosphoglyceroyl phosphate
`acid-base scale; log of reciprocal of
`hydrogen ion concentration
`phytohemagglutin
`phenylalanine
`physiological
`log of the reciprocal of the
`dissociation constant, l/log K
`phenylketonuria
`polymorphonuclear leukocyte
`inorganic pyrophosphate
`parts per million
`precipitate, precipitating
`precipitated
`plastoquinone
`propyl (normal)
`prepared
`preparation
`pressure
`proline
`5-phosphoribosyl l-pyrophosphate
`pseudo
`point
`parathyroid hormone
`coenzyme Q (ubiquinone)
`(quae vide) which see, plural
`(quad vide) which see
`“roentgen” unit of radiation
`racemic
`
`R
`
`(R)—
`
`RAST
`rbc
`RCO—
`recryst(n)
`ref
`rep [REP]
`
`resp
`Rf or RF
`
`RIA
`Rib
`RIST
`RNA
`hnRNA
`mRNA
`nRNA
`rRNA
`snRNA
`tRNA
`RNase
`RTECS
`
`s-
`S
`
`(S)—
`
`S.A.E.
`SAM
`sapon(if)
`at
`satd
`- s.c.
`SDS
`sec
`sec—
`sepn
`Ser
`SI
`SLE
`SNRI
`
`
`
`sol; soly
`solidif
`soln
`sp.
`spec
`SPECT
`
`sp gr
`spp.
`sq
`sag
`SRBC
`SRS-A
`
`~ss
`SSPE
`SSRI
`S.T.P.
`subl
`SUPP1
`sym-
`syn-
`
`T
`t1,2
`tabl
`
`xvii
`
`0007
`
`alkyl, univalent hydrocarbon radical
`(or hydrogen)
`rectus (right), stereodescriptor see
`Glossary
`radioallergosorbent test
`red blood cell; red blood count
`aliphatic acyl radical
`recrystallize, recrystallization
`reference
`
`‘ ‘roentgen equivalent physical”
`means a dose of ionizing radiation
`capable of producing energy
`absorption of 93 ergs per gram of
`tissue
`respectively
`(in paper chromatography) ratio of
`movement of the band to the front
`of the solvent
`radioimrnunoassay
`D—ribose
`radioimmunosorbent test
`ribonucleic acid
`heterogeneous nuclear RNA
`messenger RNA
`nuclear RNA
`ribosomal RNA
`small nuclear RNA
`transfer (soluble) RNA
`ribonuclease
`
`Registry of Toxic Eflects of Chemical
`Substances
`symmetrical
`denoting attachment to sulfur as in
`S-methylcysteine
`sinister (left), stereodescriptor see
`Glossary
`Society of Automotive Engineers
`S—adenosylmethionjne
`saponification
`sarcosine
`saturated
`subcutaneous
`sodium dodecyl sulfate
`second(s)
`secondary
`separation
`serine
`
`International System of Units
`systemic lupus erythematosus
`serotonin—noradrenaline reuptake
`inhibitor
`soluble; solubility
`solidifies, solidification
`solution
`species; specific
`spectroscopy
`single photon emission computed
`tomography
`specific gravity
`species (plural)
`square
`(sequentia) and following
`sheep red blood cells
`slow reacting substance of
`anaphylaxis
`single stranded
`subacute sclerosing panencephalitis
`selective serotonin reuptake inhibitor
`standard temperature and pressure
`sublimes
`supplement
`symmetrical
`stereochernical descriptor see
`Glossary
`thymine; thymidine
`half—life
`tablet(s)
`
`0007
`
`

`

`tuberculosis
`trichloroacetic acid; tricarboxylic
`acid
`thymus derived cell
`thoracic duct lymphocyte
`thyrnidine diphosphate
`0—(triethylaminoethyl)—cellulose
`technical
`temperature
`tertiary
`thyrotropic hormone
`tetrahydrofuran
`tetrahydrofolic acid
`threonine
`thymine
`thin-layer chromatography
`thymidine 5 ’—monophosphate
`tobacco mosaic virus
`tumor necrosis factor
`trinitrophenyl
`tissue plasminogen activator
`thiamine pyrophosphate
`stereodescriptor see Glossary
`tris(hydroxymethyl)aminomethane;
`2—anuno—Z—hydroxymethylpropane-
`1,3-diol
`tryptophan
`thyroid—stimulating hormone
`tumor—specific transplantation
`antigens
`thymidine triphosphate
`tyrosine
`uracil or uridine
`uridine diphosphate
`uridine diphosphogalactose
`uridine disphosphoglucose
`United Kingdom
`uridine 5’—monophosphate (uridylic
`acid)
`uncorrected
`
`unsymmetrical, asymmetrical
`uracil
`
`United States Atomic Energy
`Commission
`United States Adopted Names
`
`
`
`
`
`U.S.D.
`U.S.D.A.
`
`U.S.P.
`U.S. pat.
`UTP
`uv
`v
`1/-
`Val
`var
`viz.
`VLDL
`vol
`vs
`v/v
`
`Wbc
`WHO
`wks
`wt
`w/v
`
`w/w
`
`XMP
`yr(s)
`Z
`(2)-
`
`Z. Physiol.
`
`~
`2
`
`>
`<
`
`United States Dispensaz‘ory
`United States Department of
`Agriculture
`United States Pharmacopeia
`United States patent
`uridine triphosphate
`ultraviolet
`volt(s)
`vicinal (adjacent)
`valine
`variety
`(videlicet) that is to say; namely
`very low density lipoproteins
`volume
`versus
`
`percent “volume in volume”
`expresses the number of milliliters
`of an active constituent in 100
`milliliters of solution
`White blood cell; white blood count
`World Health Organization
`weeks
`weight
`percent “weight in volume”
`expresses the number of grams or"
`an active constituent in 100
`milliliters of solution, and is used
`regardless of whether water or
`another liquid is the solvent
`percent “weight in weight”
`expresses the number of grams of
`an active constituent in 100 grams
`of solution or mixture
`Kanthosine monophosphate
`year(s)
`carbobenzoxy
`zusammen stereodescriptor see
`Glossary
`Hoppe-Seyler’s Zeitschn'ftfi'ir
`Physiologische Chemie
`approximately
`approximately equal
`greater than
`less than
`
`xviii
`
`0008
`
`TB, tb
`TCA
`
`T cell
`TDL
`TDP
`TEAE cellulose
`tech
`
`temp
`tert—
`TH
`THF
`THZFA
`Thr
`Thy
`TLC
`TMP
`lM V
`TN?
`TN?
`TPA
`TPP, ThI-‘P
`trans—
`Tris
`
`Tr?
`rsn
`TSTA
`
`TTP, dTTP
`Tyr
`
`UU
`
`DP
`UDP—gal
`UDP—glc
`U. K.
`UMP
`
`uncor{r)
`uns—, unsym—
`Ura
`U.S.A.E.C.
`
`USAN
`
`0008
`
`

`

`I 2384
`
`Citramalic Acid
`
`Separation of isomers: Naves, Bull. Soc. Chim.
`neral.
`France 1952, 521. Comprehensive reviews: J. L. Simonsen,
`The Terpenes, vol. I, 83-100 (1947); E. Guenther, The Essenv
`tial Oils, VOL II, 326-336 (1949); Gildemeister-Hoffmann,
`Die Aetherischen 0219, vol. IV, 307-356 (4th ed., 1956).
`
`ago
`
`CH3
`
`l
`
`0,2
`
`|
`
`CH3
`
`H3C
`
`CH3
`
`H30
`
`CH3
`
`Geranial (Citral a)
`
`Neral (Citral b)
`
`Geranial, light oily liquid. Strong lemon odor. bP2.5 92-
`93°.
`dfio 0.8888.
`nfl’ 1.48982. Practically insol in water.
`Miscible with alc, ether, benzyl benzoate, diethyl phthalate,
`glycerol, propylene glycol, mineral oil, essential oils.
`Neral, light oily liquid. Lemon odor not as intense but
`sweeter than gerianal. hp” 91-92“. d5” 0.8869. ng’ 1.48690.
`Solubilities same as gerianal.
`USE:
`In the synthesis of vitamin A, ionone and methyl-
`ionone. As a flavor, for fortifying lemon oil.
`In perfumery
`for its citrus effect in lemon and verbena scents, in cologne
`odors, in perfumes for colored soaps. Not stable to alkalies
`and strong acids. Will cause discoloration of white soaps
`and alkaline cosmetics.
`
`2384. Citramalic Acid. 2-Hydroxy-2-methylbutanedioic
`acid; 2-methylmalic acid; 2-hydroxy-2-methylsuccinic acid;
`a-hydroxypyrotartaric acid. C5H305; mol wt 148.12. C
`40.55%, H 5.44%, O 54.01%. Enzymatic synthesis: Barker,
`Blair, Biachem. Prepns. 9, 21 (1962). Chemical synthesis:
`Barker, ibid. 25; J. B. Wilkes, R. G. Wall, J. Org. Chem. 45,
`247 (1980). Stereoselective synthesis: E. G. J. Staring et al.,
`Rec. Trav. Chim. 105, 374 (1986).
`H0
`CH3
`
`COOH
`
`HOOC
`
`.
`
`mg! _23.4° (c
`
`[0412} +23.6° (c = 3 in
`=3in
`
`til-Form, deliquescent monoclinic prisms from ethyl ace-
`tate + petr ether, mp 117°. Sublimes. Freely sol in water,
`acetone. Sol in ethyl acetate, ether. Practically insol in petr
`ether, benzene.
`d-Forrn, crystals, mp 112.2-112.8°.
`H20).
`I-Forrn, crystals, mp 112-113“.
`H20).
`3-Hydroxy-8’—apo-fi,xl/-car0tenal;
`2385. B-Citraul‘in.
`citraurin. CmeOZ; mol Wt 432.65. C 83.29%, H 9.32%, O
`7.40%. Carotenoid pigment found only in orange peel.
`Isoln by chromatography: Zechmeister, Tuzson, Ber. 69,
`1878 (1936); 70, 1966 (1937). The peels from 100 kilos of
`oranges yield about 35 mg. Structure: Zechmeister, Tuz-
`son,
`loc. cit; Karrer, Solmssen, Helv. Chim. Acta 20, 682
`(1937); Karrer et al.,
`ibid. 1020; Zechmeister, v. Cholnoky,
`Ann. 530, 291 (1937); Karrer et al., Helv. Chim. Acta 21, 445
`(1938). Abs config: Bartlett et al., J. Chem. Soc. (C) 1969,
`2527. Synthesis: H. Pfander et al., Helv. Chim. Acta 63,
`1377 (1980).
`
`
`
`Thin orange or yellow-colored plates from benzene + petr
`ether, mp 147°. Absorption max (benzene): 497, 467 nm.
`‘4,
`.4..- v c...
`Freely sol in acetone ethanol, ether, benzene, and ”firm
`disulfide. Sparingly sol in petr ether.
`
`
`
`
`
`
`1,2-Dihydm-6—hydrox_y.2~
`2386. Citrazinic Acid.
`,'
`pyridinecarboxylic acid; 2,6—dihydroxyisonicatinic acidlfxoq
`
`1
`dihydroxy-4-pyridinecarboxylic acid. C6H5N04; m;
`1 w
`155.11. C 46.46%, H 3.25%. N 9.03%, 0 41.26%.
`from citric acid with aq NH3 at 140-160° under pregrfl!
`
`Bavley, Hamilton, U.S. pat. 2,729,647 (1956 to Print) “hr
`rification: Bavley et al., US. pat. 2,738,352 (1955 to P};tr) [3'
`OH
`HO
`N
`/
`
`
`\
`
`l
`
`COOH
`
`Yellowish powder with a greenish tinge; carboniZes 31$ ,
`300° without melting. Ultrapure material which is Whiteove’01"
`. colorless, has been prepared. Almost insol in water; 3“
`ghtly,
`sol in hot HCl; sol in alkali hydroxide or carbonate sol“ _
`Alkaline solns turn blue on standing.
`
`‘
`
`
`2—Hydroxy-1,2,3-prapanetrimrba1" .
`2387. Citric Acid.
`ylic acid; B-hydroxytricarballylic acid. C6H807; mOlfw ;
`192.13. c 37.51%, H 4.20%, 0 58.29%. Widely distribfif’t",'
`
`in plants and in animal tissues and fluids. Producediid‘
`mycological fermentation on an industrial scale using (£de
`sugar solns, such as molasses and strains of Aspergm
`niger: See review by Von Loesecke, Chem. & Eng. News 1
`
`1952 (1945); Schweiger, U.S. pat. 2,970,084 (1961 to Mil
`Labs); Faith, Keyes & Clark’s Industrial Chemicals, F_‘
`
`Lowenheim, M. K. Moran, Eds. (Wiley-Interscience,‘ Ne
`
`York, 4th ed., 1975) pp 275-279. Also extracted from citrus
`fruits (lemon juice contains 5 to 8%) and from pi'neap
`
`waste. Reviews: Wilson, Chem. & Met. Eng. 29, 787 (1923).
`Browne, Ind. Eng. Chem. 13, 81 (1921); Warneford, Hardy":
`ibid. 17, 1283 (1925); E. F. Bouchard, E. G. Merrittjh;
`
`Kirk—Othmer Encyclopedia of Chemical Technology vol. “5
`(Wiley-Interscience, New York, 3rd ed., 1979) pp 150-5179.
`
`Toxicity: Gruber, Halbeisen, J. Pharmacol. Exp. Ther. 9
`65 (1948).
`
`
`COOH
`
`HO—C—COOH
`
`COOH
`
`
`
`Anhydr form, mp 153°. Crystals are monoclinic holoi
`_
`hedra and crystallize from hot concd aq soln. d 1.665., At
`
`25°, pKl 3.128; pK2 4.761; sz 6.396, Bates, Pinching,IJ. ,
`
`Am. Chem. Soc. 71, 1274 (1949). Soly in water: 54.0% W/
`1‘
`at 10°; 59.2% at 20°; 64.3% at 30°; 68.6% at 40°; 70.9% at'5 ._
`
`73.5% at 60°; 76.2% at 70°; 78.8% at 80°; 81.4% at 90°; 84.0%."
`at 100°.
`,
`_.
`Monohydrate, orthorhombic crystals from cold aq schist
`Pleasant, sour taste. d 1.542. Monohydrate crystals 1059.
`water of crystn in dry air or when heated at about 40 to 503”
`slightly deliquescent in moist air.
`Softens at 75°-
`13113.”-
`~100°. pH of 0.1N soln = 2.2. Densities of aqueous 50111
`(15°/15°):
`10% = 1.0392; 20% = 1.0805; 30% = 1.124le
`40% = 1.1709; 50% = 1.2204; 60% = 1.2738.
`Soly 1.11,
`g/ 100 g satd soln:
`ether 2.17; chloroform 0.007; 2111131
`alcohol 15.43; amyl acetate 5.98; ethyl acetate 5.28. Soly at}
`19° in g/ 100 g solvent: methanol 197; propanol 62.8. 111359,
`i.p. in rats: 975 mg/kg (Gruber, Halbeisen).
`’.
`-
`Pharmaceutical Incompatibilities: Potassium tartrate, 31'
`kali and alkaline earth carbonates and bicarbonates, 355'
`tates, sulfides. Dilute aq solns may ferment on standing-
`Barium salt heptahydrate, CnHmBasouflHZO, barium
`citrate. Powder. Loses all H20 at 150°. Sol in 1750 PM."S
`water; freely sol in dil HCl or HNOa; practically ins01 in
`alcohol.
`.
`.
`Ethyl ester, 012132007, ethyl citrate, triethyl citrate. Bittelz
`oily liq. d” 1.137. bp76° 294°; pr0 127°. Viscosity at 25:
`35.2 cps. Pour pt ~10°.
`nZD” 1.4455. Soly: water ~6-9%’
`peanut oil 0.8%. Misc with alc, ether.
`t
`USE: Acidulant in beverages, confectionery, effervesce”
`salts, in pharmaceutical syrups, elixirs, in effervescent poW'
`ders and tablets, to adjust the pH of foods and as Syner',
`
`Page 392
`
`Consult the Name Index before using this section.
`
`0009
`
`0009
`
`

`

`
`
`fl-Citronellol
`
`2391
`
`antioxidant, in processing cheese. Used in beverages,
`gistlc
`’eS: jams, preserves and candy to provide tartness. In the
`jelll 11f of alkyd reSins; in esterified form as plasticizer, foam
`whitor-
`In the manuf of citric acid salts. As sequestering
`ill111 t to remove trace metals. As mordant to brighten
`gen 5. in electroplating; in special inks; in analytical chem-
`1:010r for determining citrate—soluble P205; as reagent for
`15‘” in, mucin, glucose, bile pigments.
`”117 ERA? CAT: Component of anticoagulant citrate solns
`(agate dextrose soln; citrate phosphate dextrose soln; citric
`acid syrup)-
`(3R-trans)-4,6-Dihydro-8-hydroxy-3,4,5—
`2338, Citrinill.
`. ethyl—6—0xa—3H-2-benz0pyran-7-carbaxylic acid; Antimy-
`W” C13H1405; mol Wt 250.25. c 62.39%, H 5.64%, o
`C‘n'97%_ Antibiotic substance produced by a White spore
`31’ rgfllus which has been placed under the species name
`aspergillus niveus (Thorn and Raper). Also produced in
`ASP?“ quantities by Penicillium citrinum: Hetherington,
`szmck, Trans. Roy. Soc. London 3220, 269 (1931); Rais-
`R?‘k Smith, Chem. & Ind (London) 60, 828 (1941); Timo-
`‘r-‘C :Science 96, 494 (1942); Timonin, Rovatt, Can. J. Pub.
`Innlilth 35, 80 (1944).
`Identity with antimycin: Haese,
`frem Pharm. 296, 227 (1963). Structure: Brown et al., J.
`Chem- Soc. 1949, 867; Warren et al., J. Am. Chem. Soc. 79,
`3812 (1957); Kovac et (11., Nature 190, 1104 (1961). Synthe-
`iS' Cartwright et al., J. Chem. Soc. 1949, 1563; J. A. Bar-
`f”; e, 41,, J. Chem. Soc. Perkin Trans. I 1986, 2101. Stereo-
`chemiStryi Cram, J. Am. Chem. Soc. 72, 1001 (1950); Meh-
`ta Whalley’ J. Chem. Soc. 1963, 3777; Mathieson, Whalley,
`ibia'. 1964, 4640. Physical characteristics and toxicity:
`Nagai 81‘ £11., Chem. Zentr. 1958, 8088', CA. 55, 1914 (1961).
`' Crystal and molecular structure: Rodig, Chem. Commun.
`1971, 1553. Biosynthesis:
`J. Barber et aI., J. Chem. Soc.
`Perkin Trans. I 1981, 2577; L. Colombo et 11]., nibid. 2594.
`Physicochemical data: A. E. Pohland et (11., Pure Appl.
`Chem. 54, 2219 (1982). Toxicology: A. M. Ambrose, F. De
`Eds, J. Pharmacol. Exp. Ther. 88, 173 (1946). Review: Saito
`let (1]., “Yellowed Rice Toxins” in Microbial Toxins, A. Cieg-
`153-, S. Kadis, A. Ajl, Eds. (Academic Press. New York,
`{1971) vol. VI, pp 357-367.
`
`HOOC
`
`o
`
`OH
`
`~CH3
`
`CH,
`
`CH,
`
`[0433
`Lemon-yellow needles from alcohol, dec 175°.
`—37.4° (c = 1.15 in alc.). uv max: 250, 331 nm (E1211. 370,
`413). Strong acid. Practically insol in water. Sol in alco-
`1101, dioxane, dilute alkali. Solns change color with changes
`111 PH. from lemon-yellow at pH 4.6 to cherry-red at pH
`9.9. Poisonous!
`LDSO in mice, rats (mg/kg):
`35, 67 i.p.
`(Ambrose, De Eds).
`Igethyl citrinin, CHI-I160? plates from benzene, dec 139°.
`la] +217.1° (c = 0.38 in acetone). uv max: 260, 334 nm
`E161. 520, 151.6).
`Sol
`in hot alcohol; moderately sol in
`chloroform. Practically insol in petr ether.
`Dlhydrocitrinin, C13H1605’ prisms from benzene, dec
`3;};
`[00138 ~18.8° (c = 4.148 in chloroform).
`uv max:
`rofi; 330 nm (E13; 400, 100). So] in alcohol, acetone, chlo—
`rm; sparingly sol in benzene, petr ether.
`4112:189- Citromycetin.
`8,9-Dihydr0xy-2-methyl-4-axo-
`qufi’tnt' ‘Pyrqtto[3,2-c][1]benz0pyran-10-carbaxylic acid; fre-
`347‘710 acid. C14H1007; mol Wt 290.23. C 57.94%, H
`Gilli“; 0 38.59%. Antibiotic substance produced by Peni-
`y Cir frequentans Westling and P. vesiculosum Bainier and
`0y. S’Omyces Spp: Hetherington, Raistrick, Phil. Trans.
`Natureoc. London, Ser. B, 220, 209 (1931); Grove, Brian,
`Chem 5357, 995 (1951). Structure: Robertson et al., J.
`1958 '45°C~ 1951, 2013. Biosynthesis: Birch et al.,
`ibid.
`Sis:
`in ‘76; Money, Nature 199, 592 (1963). Total synthe-
`395'“. {amaUChi et al., J. Chem. Soc. Perkin Trans. I 1987,
`
`
`
`HO
`
`HO
`
`HOOC
`
`0
`
`0
`
`/
`o /
`
`CH,
`
`Dihydrate, yellow crystals, effervescence at 155°, dec 290-
`300" (considerable antecedent blackening).
`Freely sol
`in
`ethanol; readily sol in aq sodium carbonate soln; sparingly
`sol in water, chloroform.
`Insol in benzene, hexane. Stable
`to acid and alkali at 100°.
`
`C10H130§
`3, 7-Dimethyl-6-octenal.
`2390. Citronellal.
`mol wt 154.25. C 77.87%, H 11.76%, 0 10.37%. Chief
`constituent of citronella oil; also found in many other vola-
`tile oils, such as lemon, lemon grass, melissa: Tiemann, Ber.
`32, 834 (1899); Spoon, Chem. Weekbl. 54, 236 (1958).
`Structure: Naves, Bull. Soc. Chim. France 1951, 505;
`Eschinazi, J. Org. Chem. 26, 3072 (1961).
`CH,
`
`HC§
`
`H,C
`
`CH,
`
`d 0.848-
`[04E5 +11.50°.
`n}? 1.4460.
`bp1 47°.
`Liquid.
`0856. Soluble in alcohols; very slightly sol in Water.
`a-citranellal, 3,7-Di

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket